107 related articles for article (PubMed ID: 24535562)
1. Association between VKORC1 gene polymorphisms and ischemic cerebrovascular disease in Chinese Han population.
Zhang H; Yang L; Feng Q; Fan Y; Zheng H; He Y
J Mol Neurosci; 2014 Jun; 53(2):166-70. PubMed ID: 24535562
[TBL] [Abstract][Full Text] [Related]
2. G-1639A but Not C1173T
Dubovyk YI; Harbuzova VY; Ataman AV
Biomed Res Int; 2016; 2016():1298198. PubMed ID: 27703968
[TBL] [Abstract][Full Text] [Related]
3. VKORC1 -1639G/A and 1173 C/T Genetic Polymorphisms Influence Individual Differences in Warfarin Maintenance Dose.
Li Y; Zhu J; Ding J
Genet Test Mol Biomarkers; 2015 Sep; 19(9):488-93. PubMed ID: 26167638
[TBL] [Abstract][Full Text] [Related]
4. Association of functional VKORC1 promoter polymorphism with occurrence and clinical aspects of ischemic stroke in a Greek population.
Ragia G; Marousi S; Ellul J; Manolopoulos VG; Tavridou A
Dis Markers; 2013; 35(6):641-6. PubMed ID: 24288433
[TBL] [Abstract][Full Text] [Related]
5. Frequency of Common VKORC1 Polymorphisms and Their Impact on Warfarin Dose Requirement in Pakistani Population.
Qayyum A; Najmi MH; Mansoor Q; Irfan M; Naveed AK; Hanif A; Kazmi AR; Ismail M
Clin Appl Thromb Hemost; 2018 Mar; 24(2):323-329. PubMed ID: 27879469
[TBL] [Abstract][Full Text] [Related]
6. VKORC1 haplotypes in five East-Asian populations and Indians.
Lee MT; Chen CH; Chuang HP; Lu LS; Chou CH; Chen YT; Liu CY; Wen MS; Lu JJ; Chang CF; Wu JY; Chen YT
Pharmacogenomics; 2009 Oct; 10(10):1609-16. PubMed ID: 19842934
[TBL] [Abstract][Full Text] [Related]
7. Association of VKORC1-1639G>A polymorphism with susceptibility to ossification of the posterior longitudinal ligament of the spine: a Korean study.
Chin DK; Han IB; Ropper AE; Jeon YJ; Kim DH; Kim YS; Park Y; Teng YD; Kim NK; Kuh SU
Acta Neurochir (Wien); 2013 Oct; 155(10):1937-42. PubMed ID: 23732872
[TBL] [Abstract][Full Text] [Related]
8. A vitamin K epoxide reductase-oxidase complex gene polymorphism (-1639G>A) and interindividual variability in the dose-effect of vitamin K antagonists.
Stepien E; Branicka A; Ciesla-Dul M; Undas A
J Appl Genet; 2009; 50(4):399-403. PubMed ID: 19875892
[TBL] [Abstract][Full Text] [Related]
9. Influence of VKORC1 and CYP2C9 Polymorphisms on Daily Acenocoumarol Dose Requirement in South Indian Patients With Mechanical Heart Valves.
Kalpana SR; Bharath G; Manjunath CN; Christopher R
Clin Appl Thromb Hemost; 2017 Oct; 23(7):876-882. PubMed ID: 27335128
[TBL] [Abstract][Full Text] [Related]
10. Role of the vitamin K epoxide reductase complex subunit 1 (VKORC1) -1639G>A gene polymorphism in patients with retinal vein occlusion.
Weger M; Steinbrugger I; Renner W; Pöschl EM; Brockmann T; Rabensteiner DF; El-Shabrawi Y; Haas A
Curr Eye Res; 2013 Dec; 38(12):1278-82. PubMed ID: 23972066
[TBL] [Abstract][Full Text] [Related]
11. Pharmacogenetics-Based Warfarin Dosing in Patients With Cardiac Valve Replacement: The Effects of CYP2C9 and VKORC1 Gene Polymorphisms.
Farzamikia N; Sakhinia E; Afrasiabirad A
Lab Med; 2017 Dec; 49(1):25-34. PubMed ID: 29182754
[TBL] [Abstract][Full Text] [Related]
12. Contribution of 1173C > T polymorphism in the VKORC1 gene to warfarin dose requirements in Han Chinese patients receiving anticoagulation.
Yang J; Huang C; Shen Z; Miao L
Int J Clin Pharmacol Ther; 2011 Jan; 49(1):23-9. PubMed ID: 21176721
[TBL] [Abstract][Full Text] [Related]
13. Association between Vitamin K Epoxide Reductase (VKORC1) -1639G>A Polymorphism and Osteoporosis in Postmenopausal Women.
Kutluturk F; Inanir A; Rustemoglu A; Kaya SU; Demir AK; Dursun G; Yigit S
Endocr Metab Immune Disord Drug Targets; 2018; 18(3):281-286. PubMed ID: 29437025
[TBL] [Abstract][Full Text] [Related]
14. Cytochrome P450 2C9 (CYP2C9) and vitamin K epoxide reductase (VKORC1) genotypes as determinants of acenocoumarol sensitivity.
Bodin L; Verstuyft C; Tregouet DA; Robert A; Dubert L; Funck-Brentano C; Jaillon P; Beaune P; Laurent-Puig P; Becquemont L; Loriot MA
Blood; 2005 Jul; 106(1):135-40. PubMed ID: 15790782
[TBL] [Abstract][Full Text] [Related]
15. [Impact of CYP2C9 and VKORC1 polymorphism on warfarin response during initiation of therapy].
Liu Y; Zhong SL; Tan HH; Yang M; Fei HW; Yu XY; Lin SG
Zhonghua Xin Xue Guan Bing Za Zhi; 2011 Oct; 39(10):929-35. PubMed ID: 22321278
[TBL] [Abstract][Full Text] [Related]
16. Vitamin K epoxide reductase genetic polymorphism is associated with venous thromboembolism: results from the EDITH Study.
Lacut K; Larramendy-Gozalo C; Le Gal G; Duchemin J; Mercier B; Gourhant L; Mottier D; Becquemont L; Oger E; Verstuyft C
J Thromb Haemost; 2007 Oct; 5(10):2020-4. PubMed ID: 17883698
[TBL] [Abstract][Full Text] [Related]
17. Single nucleotide polymorphisms in the VKORC1 gene and the risk of stroke in the Southern German population.
Arnold ML; Lichy C; Werner I; Radbruch A; Wagner S; Grond-Ginsbach C
Thromb Haemost; 2008 Oct; 100(4):614-7. PubMed ID: 18841283
[TBL] [Abstract][Full Text] [Related]
18. VKORC1 gene polymorphisms and adverse events in Croatian patients on warfarin therapy.
Mandic D; Bozina N; Mandic S; Samardzija M; Milostic-Srb A; Rumora L
Int J Clin Pharmacol Ther; 2015 Nov; 53(11):905-13. PubMed ID: 26445138
[TBL] [Abstract][Full Text] [Related]
19. Association between VKORC1 gene polymorphism and warfarin dose requirement and frequency of VKORC1 gene polymorphism in patients from Kerman province.
Soltani Banavandi MJ; Satarzadeh N
Pharmacogenomics J; 2020 Aug; 20(4):574-578. PubMed ID: 31902949
[TBL] [Abstract][Full Text] [Related]
20. [Association of VKORC1 gene -1639G/A polymorphism with atrial fibrillation in ethnic Uygurs and Hans from Xinjiang].
Wu P; Meng S; Zhou X; Xu G; Li J; Zhang Y; Sun L; Xing Q; Sun S; Wang H; Zhou Q; Tang B
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2015 Apr; 32(2):264-8. PubMed ID: 25863101
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
